Teva enters billion-dollar settlement in US opioid case

The Israeli pharmaceutical firm maintains its innocence in the opioid health crisis in the US but has agreed to pay USD 4.25bn over the next 13 years in a national settlement.

Photo: Bryan Woolston/REUTERS / X03629

Teva has entered a settlement to resolve an abundance of lawsuits filed by state and local governments in the US, according to the firm’s second quarterly report on Tuesday.

Under the deal, the Israeli pharmaceutical firm will pay USD 4.25bn to end allegations concerning its role in the opioid crisis in the US, which entailed thousands of Americans becoming addicted to opioid pain relievers.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs